Viewing StudyNCT00074282



Ignite Creation Date: 2024-05-05 @ 11:33 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00074282
Status: COMPLETED
Last Update Posted: 2023-06-29
First Post: 2003-12-10

Brief Title: Pentostatin Cyclophosphamide and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL
Sponsor: Eastern Cooperative Oncology Group
Organization: Eastern Cooperative Oncology Group

Conditions & Keywords Data

Conditions:
Name
Leukemia
Keywords:
Name View
refractory chronic lymphocytic leukemia View
B-cell chronic lymphocytic leukemia View